@article {3132714,
	title = {SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-γ, and Point Mutation in the Transcription Intermediary Factor 1-γ Coding Gene: A Case Report},
	journal = {JTO Clin Res Rep},
	volume = {2},
	number = {9},
	year = {2021},
	note = {2666-3643Arnon, JohnathanElia, AnnaNevo, YuvalLossos, AlexanderNechushtan, HovavCase ReportsJTO Clin Res Rep. 2021 Aug 9;2(9):100217. doi: 10.1016/j.jtocrr.2021.100217. eCollection 2021 Sep.},
	month = {Sep},
	pages = {100217},
	edition = {2021/10/01},
	abstract = {SCLC is frequently associated with paraneoplastic syndromes, including dermatomyositis. Patients with malignancy-associated dermatomyositis express a specific autoantibody pattern usually positive for anti-transcription intermediary factor 1-γ (TIF1-γ), suggesting anti-TIF1-γ plays a role in development of malignancy-associated dermatomyositis. We present a case of a patient with SCLC, paraneoplastic dermatomyositis, positive anti-TIF1-γ, and a point mutation in TIF1-γ coding gene, with prominent clinical response to chemoradiation. We suggest that this point mutation is pathogenic, providing evidence for the development of paraneoplastic dermatomyositis through immune cross-reactivity.},
	keywords = {Anti-TIF1-γ, Case report, Dermatomyositis, Small cell lung cancer},
	isbn = {2666-3643},
	url = {https://pubmed.ncbi.nlm.nih.gov/34590056/},
	author = {Arnon, J. and Elia, A. and Nevo, Y. and Lossos, A. and Nechushtan, H.}
}
